- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 249/08 - 1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Patent holdings for IPC class C07D 249/08
Total number of patents in this class: 1209
10-year publication summary
|
120
|
97
|
74
|
67
|
81
|
70
|
53
|
71
|
51
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20387 |
67 |
| Karyopharm Therapeutics Inc. | 141 |
39 |
| Corteva Agriscience LLC | 2680 |
37 |
| Kureha Corporation | 1024 |
31 |
| Bristol-myers Squibb Company | 4883 |
20 |
| BASF Agro B.V. | 218 |
19 |
| Bayer Cropscience AG | 2142 |
18 |
| Ardea Biosciences, Inc. | 76 |
16 |
| Dow AgroSciences LLC | 1240 |
14 |
| Merck Sharp & Dohme LLC | 3744 |
13 |
| Amgen Inc. | 3897 |
12 |
| Boehringer Ingelheim International GmbH | 4756 |
11 |
| Nippon Soda Co., Ltd. | 884 |
11 |
| Synta Pharmaceuticals Corp. | 191 |
11 |
| Janssen Pharmaceutica N.V. | 3624 |
10 |
| Novartis AG | 11289 |
9 |
| Theravance Biopharma R&D IP, LLC | 517 |
9 |
| Merck Sharp & Dohme Corp. | 2219 |
8 |
| Syngenta Participations AG | 3033 |
8 |
| Bayer Pharma AG | 1085 |
8 |
| Other owners | 838 |